NCT03943979

Brief Summary

The study aims to: 1) investigate the effects of cognitive training (CT) and combined CT and transcranial direct current stimulation (tDCS) on food intake and 2) to further understand its neuropsychological and neurophysiological basis (i.e. EEG) as well as its impact in endocannabinoids (EC) in a sample of morbidly obese patients seeking for a gastric bypass surgery

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Feb 2016

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2017

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

June 14, 2018

Completed
11 months until next milestone

First Posted

Study publicly available on registry

May 9, 2019

Completed
Last Updated

May 9, 2019

Status Verified

May 1, 2019

Enrollment Period

1.2 years

First QC Date

June 14, 2018

Last Update Submit

May 8, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in food intake

    Changes in food consumption (medium kcal intake ) from baseline to the end of the treatment measured by 4-day food registers during the week before starting the treatment and during the 4 days of treatment. The dietary records were checked by a nutritionist and analyzed through the software PCN Pro 1.0.

    4 consecutive days during the week before starting the treatment; 4 consecutive days during the week of treatment;

  • Stability of changes in food intake

    Changes in food consumption (medium kcal intake ) from baseline to the follow-up assessment measured by 4-day food registers during the week before starting the treatment and the week after finishing the treatment. The dietary records were checked by a nutritionist and analyzed through the software PCN Pro 1.0.

    4 consecutive days during the week before starting the treatment and 4 consecutive days during the week after finishing the treatment

Secondary Outcomes (12)

  • Change in electroencephalogram (EEG) power and coherence

    Every training session (4 consecutive days), 3 minutes before starting the training session and 3 minutes after finishing the training.

  • Change in Body Mass Index (BMI)

    One day during the week before starting the training (pre-treatment) and the 1 day after finishing the treatment (post-treatment)

  • Change in endocannabinoids (and related compounds) plasmatic concentrations.

    One day during the week before starting the training (pre-treatment) and the 1 day after finishing the treatment (post-treatment)

  • Change in hormonal measurements : Leptin and adiponectin plasmatic/serum concentrations

    One day during the week before starting the training (pre-treatment) and the 1 day after finishing the treatment (post-treatment)

  • Change in neuropsychological test: Intra-extra dimension (IED-CANTAB Cambridge Cognition)

    One day during the week before starting the training (pre-treatment) and the 1 day after finishing the treatment (post-treatment)

  • +7 more secondary outcomes

Study Arms (2)

Active Control group

SHAM COMPARATOR

This group will receive CT and sham tDCS each day, for four days.

Other: Cognitive Training

Active group

ACTIVE COMPARATOR

This group will receive both CT and tDCS, each day, for four days.

Other: Cognitive TrainingDevice: transcranial Direct-Current Stimulation (tDCS)

Interventions

Cognitive Training (CT): 4 consecutive days, 30-45 min session involving 5 different tasks designed to train executive functions and attention, available at the Guttmann Neuropersonaltrainer platform (computerized cognitive training tool certified by the Spanish Agency for Medicines and Health Products as a Class I Health Product). The difficulty level of all the tasks was automatically adjusted on a trial-by-trial basis for both Active and Active Control conditions.

Active Control groupActive group

tDCS: 4 consecutive days, 20 min session, delivered through multichannel tDCS (Starstim, Neuroelectrics), with an excitatory target over the r-dlPFC, and an inhibitory target on the contralateral lobe (l-dlPFC). The positioning of the multichannel tCS (electrode location and currents) was solved using the Stimweaver (Ruffini 2013). The resulting tCS montage employed 8 gelled Ag/AgCl electrodes of π cm2 size (Pistim, Neuroelectrics) placed at AF3(-1093uA), AF4 (1178uA), F3 (-1161uA), F4 (1104uA), F7 (-414uA), F8 (530uA), FC5 (1189uA), FC6 (-1332uA).

Active group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects of both gender, aged between 18 and 60 years-old
  • Having a BMI \> 40 kg/m2 or having a BMI\>35 and suffering from diabetes mellitus, HBP or LDP.
  • Obesity conventional treatment failure
  • Wish of bariatric surgery
  • Accepting the study and signing the Informed Consent

You may not qualify if:

  • Being left-handed
  • Using a pacemaker or deep cerebral stimulation device
  • Having a psychiatric disease or serious disease
  • Neurologic condition or learning issue or mental backwardness that could affect cognitive function
  • Use of psycho-stimulating medicines and/or drugs, abuse or dependance to a psychoactive substance (or during the last 6 months)
  • Dependance to alcohol or/and drugs (excepted from nicotina)
  • In treatment with benzodiazepines, antipsychotics, tricyclic antidepressants or topiramate, started in the last month
  • History of psychiatric disorders treated with lithio carbonate.
  • Cutaneous lesion on the area of using of electrodes
  • Contact allergy to material used in the used devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (12)

  • Alonso-Alonso M. Translating tDCS into the field of obesity: mechanism-driven approaches. Front Hum Neurosci. 2013 Aug 27;7:512. doi: 10.3389/fnhum.2013.00512. eCollection 2013.

    PMID: 23986687BACKGROUND
  • Barr MS, Fitzgerald PB, Farzan F, George TP, Daskalakis ZJ. Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Curr Drug Abuse Rev. 2008 Nov;1(3):328-39. doi: 10.2174/1874473710801030328.

    PMID: 19630729BACKGROUND
  • Boivin JR, Piscopo DM, Wilbrecht L. Brief cognitive training interventions in young adulthood promote long-term resilience to drug-seeking behavior. Neuropharmacology. 2015 Oct;97:404-13. doi: 10.1016/j.neuropharm.2015.05.036. Epub 2015 Jun 9.

    PMID: 26066577BACKGROUND
  • Conti CL, Moscon JA, Fregni F, Nitsche MA, Nakamura-Palacios EM. Cognitive related electrophysiological changes induced by non-invasive cortical electrical stimulation in crack-cocaine addiction. Int J Neuropsychopharmacol. 2014 Sep;17(9):1465-75. doi: 10.1017/S1461145714000522. Epub 2014 Apr 28.

    PMID: 24776374BACKGROUND
  • Corbett A, Owen A, Hampshire A, Grahn J, Stenton R, Dajani S, Burns A, Howard R, Williams N, Williams G, Ballard C. The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled Trial. J Am Med Dir Assoc. 2015 Nov 1;16(11):990-7. doi: 10.1016/j.jamda.2015.06.014.

    PMID: 26543007BACKGROUND
  • Ditye T, Jacobson L, Walsh V, Lavidor M. Modulating behavioral inhibition by tDCS combined with cognitive training. Exp Brain Res. 2012 Jun;219(3):363-8. doi: 10.1007/s00221-012-3098-4. Epub 2012 Apr 25.

    PMID: 22532165BACKGROUND
  • Gluck ME, Alonso-Alonso M, Piaggi P, Weise CM, Jumpertz-von Schwartzenberg R, Reinhardt M, Wassermann EM, Venti CA, Votruba SB, Krakoff J. Neuromodulation targeted to the prefrontal cortex induces changes in energy intake and weight loss in obesity. Obesity (Silver Spring). 2015 Nov;23(11):2149-56. doi: 10.1002/oby.21313.

    PMID: 26530931BACKGROUND
  • Goldman RL, Borckardt JJ, Frohman HA, O'Neil PM, Madan A, Campbell LK, Budak A, George MS. Prefrontal cortex transcranial direct current stimulation (tDCS) temporarily reduces food cravings and increases the self-reported ability to resist food in adults with frequent food craving. Appetite. 2011 Jun;56(3):741-6. doi: 10.1016/j.appet.2011.02.013. Epub 2011 Feb 23.

    PMID: 21352881BACKGROUND
  • Grall-Bronnec M, Sauvaget A. The use of repetitive transcranial magnetic stimulation for modulating craving and addictive behaviours: a critical literature review of efficacy, technical and methodological considerations. Neurosci Biobehav Rev. 2014 Nov;47:592-613. doi: 10.1016/j.neubiorev.2014.10.013.

    PMID: 25454360BACKGROUND
  • Jauch-Chara K, Kistenmacher A, Herzog N, Schwarz M, Schweiger U, Oltmanns KM. Repetitive electric brain stimulation reduces food intake in humans. Am J Clin Nutr. 2014 Oct;100(4):1003-9. doi: 10.3945/ajcn.113.075481. Epub 2014 Aug 6.

    PMID: 25099550BACKGROUND
  • Juarascio AS, Manasse SM, Espel HM, Kerrigan SG, Forman EM. Could training executive function improve treatment outcomes for eating disorders? Appetite. 2015 Jul;90:187-93. doi: 10.1016/j.appet.2015.03.013. Epub 2015 Mar 14.

    PMID: 25777264BACKGROUND
  • Sauvaget A, Trojak B, Bulteau S, Jimenez-Murcia S, Fernandez-Aranda F, Wolz I, Menchon JM, Achab S, Vanelle JM, Grall-Bronnec M. Transcranial direct current stimulation (tDCS) in behavioral and food addiction: a systematic review of efficacy, technical, and methodological issues. Front Neurosci. 2015 Oct 9;9:349. doi: 10.3389/fnins.2015.00349. eCollection 2015.

    PMID: 26500478BACKGROUND

MeSH Terms

Conditions

Obesity, MorbidObesityDiabetes MellitusHypertension

Interventions

Cognitive TrainingTranscranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesEndocrine System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesElectric Stimulation TherapyConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The difference between the two groups is the tDCS therapy. To mask this difference, the duration time of the session will be the same under both conditions but a standard Sham tDCS protocol will be used for the Active Control group. That is, a 3-sec ramp-up and ramp-down current stimulation, so the subject perceives the current just like the real tDCS, but it is not strong nor durable enough to have any effect on the neuronal activity.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Active Control group: Subjects will receive CT and sham tDCS during four consecutive days. Active group: Subjects will receive CT and active tDCS during four consecutive days.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

June 14, 2018

First Posted

May 9, 2019

Study Start

February 25, 2016

Primary Completion

May 26, 2017

Study Completion

June 1, 2017

Last Updated

May 9, 2019

Record last verified: 2019-05